St James Hospital,Leeds

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 21 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Regeneron Pharmaceuticals1 trial
• Takeda1 trial

Running trials

• Recruiting

  A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

  NCT05037760· Phase 2· Takeda· Source

  Contact: Chun Huat Teh (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myeloproliferative neoplasms1 recruiting

Closed trials

• Completed

  Registry of Asthma Patients Initiating DUPIXENT®

  NCT04287621· Regeneron Pharmaceuticals· Source